Thyrocare Technologies Limited (BOM:539871)
India · Delayed Price · Currency is INR 521.95
-0.15 (-0.03%)
At close: Jun 2, 2026
Thyrocare Technologies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,631 | 915.1 | 707.6 | 644.9 | 1,761 |
Depreciation & Amortization | 585.8 | 547.3 | 465.6 | 380.2 | 338.7 |
Other Amortization | - | 5.3 | 4.5 | 6.9 | - |
Loss (Gain) From Sale of Assets | -40.8 | -0.1 | 9.3 | -4.3 | -213.4 |
Loss (Gain) From Sale of Investments | -95.8 | -88.1 | -57.9 | -53.7 | -52.2 |
Stock-Based Compensation | 240.9 | 245.1 | 166.7 | 211.7 | 23.2 |
Provision & Write-off of Bad Debts | - | 12.6 | 88.3 | 95.2 | 102 |
Other Operating Activities | -103.6 | 150.6 | -9.4 | -45.7 | -33.4 |
Change in Accounts Receivable | -9.9 | -307.9 | 328.2 | -14.3 | -587.2 |
Change in Inventory | -19.2 | 9.9 | -198.5 | -31.4 | -11.7 |
Change in Accounts Payable | -108.6 | 361 | 161.2 | 74.2 | -84.8 |
Change in Other Net Operating Assets | 53.1 | 62.4 | 10.7 | 29.4 | -108.5 |
Operating Cash Flow | 2,132 | 1,913 | 1,676 | 1,293 | 1,134 |
Operating Cash Flow Growth | 11.46% | 14.13% | 29.63% | 14.02% | -1.15% |
Capital Expenditures | -208.8 | -448.9 | -615.8 | -436.5 | -378.3 |
Sale of Property, Plant & Equipment | 54 | 0.1 | 7.2 | 21 | 229.3 |
Cash Acquisitions | - | -112.6 | - | - | - |
Divestitures | - | - | - | - | 42.5 |
Investment in Securities | -106 | 16.5 | -314 | 12.6 | -136.5 |
Other Investing Activities | 30.7 | 19.7 | 9.7 | 13 | 7.3 |
Investing Cash Flow | -230.1 | -525.2 | -912.9 | -389.9 | -235.7 |
Long-Term Debt Issued | - | - | 286.2 | - | - |
Long-Term Debt Repaid | -183.9 | -320.8 | -127.5 | -55.3 | -53.8 |
Net Debt Issued (Repaid) | -183.9 | -320.8 | 158.7 | -55.3 | -53.8 |
Issuance of Common Stock | - | 0.4 | 0.2 | 0.3 | 0.3 |
Common Dividends Paid | -1,484 | -953.1 | -952.7 | -793.5 | -793.1 |
Other Financing Activities | -27.7 | -30.7 | -54.3 | -13.3 | -47.5 |
Financing Cash Flow | -1,696 | -1,304 | -848.1 | -861.8 | -894.1 |
Net Cash Flow | 206.4 | 83.8 | -84.7 | 41.4 | 4.3 |
Free Cash Flow | 1,924 | 1,464 | 1,061 | 856.6 | 755.8 |
Free Cash Flow Growth | 31.37% | 38.08% | 23.80% | 13.34% | -14.15% |
Free Cash Flow Margin | 23.20% | 21.30% | 18.54% | 16.26% | 12.83% |
Free Cash Flow Per Share | 12.08 | 9.19 | 6.67 | 5.39 | 4.75 |
Cash Interest Paid | 27.7 | 30.7 | 66.4 | 22.5 | 47.5 |
Cash Income Tax Paid | 598.2 | 413.8 | 289.9 | 284.6 | 567.6 |
Levered Free Cash Flow | 2,016 | 1,104 | 582.04 | 748.3 | 815.46 |
Unlevered Free Cash Flow | 2,033 | 1,123 | 608.29 | 762.99 | 830.28 |
Change in Working Capital | -84.6 | 125.4 | 301.6 | 57.9 | -792.2 |